These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194 [TBL] [Abstract][Full Text] [Related]
27. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286 [TBL] [Abstract][Full Text] [Related]
28. Rotavirus vaccine: early introduction in Latin America-risks and benefits. Pérez-Vargas J; Isa P; López S; Arias CF Arch Med Res; 2006 Jan; 37(1):1-10. PubMed ID: 16314179 [TBL] [Abstract][Full Text] [Related]
29. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837 [TBL] [Abstract][Full Text] [Related]
31. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life. Block SL; Vesikari T; Goveia MG; Rivers SB; Adeyi BA; Dallas MJ; Bauder J; Boslego JW; Heaton PM; Pediatrics; 2007 Jan; 119(1):11-8. PubMed ID: 17200266 [TBL] [Abstract][Full Text] [Related]
32. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants. Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513 [TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Phua KB; Lim FS; Lau YL; Nelson EA; Huang LM; Quak SH; Lee BW; Teoh YL; Tang H; Boudville I; Oostvogels LC; Suryakiran PV; Smolenov IV; Han HH; Bock HL Vaccine; 2009 Oct; 27(43):5936-41. PubMed ID: 19679216 [TBL] [Abstract][Full Text] [Related]
34. Rotavirus vaccine trial in Jamaica. Christie CD; Duncan ND West Indian Med J; 2012 Jul; 61(4):405-7. PubMed ID: 23240476 [TBL] [Abstract][Full Text] [Related]
35. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine. Dennehy PH; Goveia MG; Dallas MJ; Heaton PM Int J Infect Dis; 2007 Nov; 11 Suppl 2():S36-42. PubMed ID: 18162245 [TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. Rennels MB; Glass RI; Dennehy PH; Bernstein DI; Pichichero ME; Zito ET; Mack ME; Davidson BL; Kapikian AZ Pediatrics; 1996 Jan; 97(1):7-13. PubMed ID: 8545227 [TBL] [Abstract][Full Text] [Related]
37. RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe. Vesikari T; Itzler R; Karvonen A; Korhonen T; Van Damme P; Behre U; Bona G; Gothefors L; Heaton PM; Dallas M; Goveia MG Vaccine; 2009 Dec; 28(2):345-51. PubMed ID: 19879226 [TBL] [Abstract][Full Text] [Related]